Infertility Drugs

Infertility of women - Analysis of drug pipeline and market forecasts to 2016

Summary

The new report from the expert analysis of the industry, "Infertility in women - Drug Pipeline Analysis and Forecasts to 2016" is an essential source of information and analysis on the market for infertility women in the world. The report identifies key market trends driving the development and female infertility in the world. The report also gives an overview of the prevailing competitive landscape and emerging players should bring significant changes in the positioning of market leaders in the existing market. More importantly, the report provides valuable information on the products pipeline in the area of infertility of women in the world.

This report is built using data and information from proprietary databases, the primary and secondary research and analysis GlobalData internal team of specialists in the industry.

Scope

The report analyzes the opportunities and challenges for the global market for women's disease of infertility. Includes
- Annualized global women infertility disease market revenue data from 2001 to 2009, forecasts for the seven years to 2016.
- The geographic markets covered in this report are the United States, the United Kingdom, Italy, Spain, Germany, France and Japan.
- Analysis of data providing a pipeline split between the different phases, mechanisms of action in development and new trends. Classes key mechanism of action include GnRH antagonists, AMP-activated protein kinase (AMPK) agonists, luteinizing hormone and beta 2 receptor agonists.
- Analysis of current and future competitors in the market for infertility of women in the world. The key market players are covered Merck Serono SA, Ferring Pharmaceuticals, Dong-A Pharmaceutical Co., Ltd. and PregLem SA.
- Review in depth the key drivers of the sector, constraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key themes include strategic competitor assessment, characterization of the market, unmet needs and market implications of female infertility future.

For more information, please visit:

http://www.aarkstore.com/reports/Women 's-and infertility drug-pipeline-analysis-and-market-forecast-to-2016-39937.html

Or email or call +919272852585 press@aarkstore.com

Aarkstore Enterprise

Tel: +912227453309

Mobile No: +919272852585

Email: contact@aarkstore.com

Website: http://www.aarkstore.com

Blog: http://blogs.aarkstore.com/

Follow us on Twitter: http://twitter.com/aarkstoredotcom